Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free cyclosporine versus sodium hyaluronate for dry eye after phacoemulsification
ChiCTR2400080952Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Feb 2024
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine and sodium hyaluronate in dry eye syndrome (DED) (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Ocular Surface Disease Index score. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
cyclosporinesodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2400080952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080952.